Balaraman Kalyanaraman

17PUBLICATIONS
31CO-AUTHORS
Molecular targetsPharmacogenomicsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 22, 2026
Mitochondria-targeted metformin analogs activate the ER stress-unfolded protein response pathway to drive apoptosis in pancreatic cancer.

|Jan 28, 2026
Microbial Metabolism of Levodopa as an Adjunct Therapeutic Target in Parkinson's Disease.

Jimmy B Feix, Gang Cheng, Micael Hardy

|Jan 25, 2025
Enhancing Radiation Therapy Response in Prostate Cancer Through Metabolic Modulation by Mito-Lonidamine: A 1H and 31P Magnetic Resonance Spectroscopy Study.

Stepan Orlovskiy, Pradeep Kumar Gupta, Fernando Arias-Mendoza

|May 30, 2024
Mitigating gut microbial degradation of levodopa and enhancing brain dopamine: Implications in Parkinson's disease.

Gang Cheng, Micael Hardy, Cecilia J Hillard

|May 04, 2023
Antiproliferative effects of mitochondria-targeted N-acetylcysteine and analogs in cancer cells.

Gang Cheng, Micael Hardy, Balaraman Kalyanaraman

|Feb 25, 2023
Polyphenolic Boronates Inhibit Tumor Cell Proliferation: Potential Mitigators of Oxidants in the Tumor Microenvironment.

Gang Cheng, Hakim Karoui, Micael Hardy

Pageof 3

Frequent Collaborators

4 joint publications

Micael Hardy

2 joint publications

Ben-Zhan Zhu

2 joint publications

Jacek Zielonka

1 joint publications

Stéphane Gastaldi